캘리포니아의 유방암 임상 시험
유방암 관련 연구 178개가 캘리포니아 내 여러 지역에서 참여자를 모집하고 있습니다.
캘리포니아의 도시
- Los Angeles연구 71개
- Baldwin Park연구 45개
- San Francisco연구 43개
- San Diego연구 41개
- Santa Monica연구 27개
- Mountain View연구 24개
- Irvine연구 23개
- Sacramento연구 20개
- Newport Beach연구 16개
- Orange연구 14개
- Santa Rosa연구 10개
- Vallejo연구 10개
- Burbank연구 9개
- Fullerton연구 9개
- Torrance연구 9개
- Long Beach연구 9개
- Concord연구 8개
- Stockton연구 7개
- Richmond연구 7개
- Roseville연구 7개
- Oakland연구 7개
- Westminster연구 7개
- Santa Clara연구 6개
- Fresno연구 6개
- San Jose연구 6개
- Fremont연구 6개
- Redwood City연구 6개
- Pleasanton연구 6개
- Indio연구 6개
- Huntington Beach연구 6개
- Santa Barbara연구 6개
- Modesto연구 5개
- Anaheim연구 5개
- Santa Maria연구 5개
- San Leandro연구 4개
- Bakersfield연구 4개
- Vacaville연구 4개
- Riverside연구 4개
- Daly City연구 4개
- San Marcos연구 4개
- Antioch연구 4개
- Glendale연구 4개
- Pasadena연구 4개
- Elk Grove연구 4개
- Arden-Arcade연구 4개
- Whittier연구 4개
- Alhambra연구 4개
- San Bernardino연구 4개
- Santa Clarita연구 3개
- Ontario연구 3개
- Salinas연구 3개
- Bellflower연구 3개
- Norwalk연구 3개
- Sunnyvale연구 3개
- San Mateo연구 3개
- Upland연구 3개
- Berkeley연구 3개
공식 연구 텍스트(영어)
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- The Oncology Institute of Hope and Innovation, Cerritos
- Ellison Medical Institute, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
- 외 3개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06324357Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- California Protons Cancer Therapy Center, San Diego
피험자 모집 중2상
50세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT01766297Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- California Protons Cancer Therapy Center, San Diego
피험자 모집 중3상
19세 이상 · 여성 · 2026. 9. 29. 업데이트됨 · NCT05856773A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Newport Beach
- 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05877599Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Onco Inst of Hope and Innovation, Cerritos
- City of Hope National Medical, Duarte
- Providence Medical Foundation, Fullerton
- 외 7개
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05827081IKS014 in Advanced Solid Tumors That Express HER2
- Hoag Memorial Hospital Presbyterian, Newport Beach
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05872295A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- Los Angeles Hematology Oncology Medical Group ( Site 0026), Los Angeles
- Hoag Memorial Hospital Presbyterian ( Site 0025), Newport Beach
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07060807A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Fountain Valley
- Research Site, Glendale
- Research Site, Sacramento
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- City of Hope, Duarte
- UC San Diego Moores Cancer Center, La Jolla
- UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07007559The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Providence Medical Foundation, Eureka
- Providence Medical Foundation, Santa Rosa
피험자 모집 중3상
60세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06377852A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
- Los Angeles Cancer Network, Los Angeles
- Community Clinical Trials, Orange
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 25. 업데이트됨 · NCT07054190A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Providence Medical Foundation-Oncology ( Site 0020), Fullerton
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06312176A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06172478A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Roy and Patricia Disney Family Cancer Center ( Site 0055), Burbank
- Community Cancer Institute ( Site 0100), Clovis
- Providence Medical Foundation ( Site 0080), Fullerton
- 외 4개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT07229313Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Beverly Hills
- Clinical Trial Site, La Jolla
- Clinical Trial Site, Los Alamitos
- 외 8개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Marin Cancer Care, Greenbrae
- Loma Linda University, Loma Linda
- Cancer and Blood Research Center, Los Alamitos
- 외 3개
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
- Precision NextGen Oncology and Research Center (Investigational Site number USA-001), Beverly Hills
피험자 모집 중1상
18세 ~ 80세 · 여성 · 2026. 9. 23. 업데이트됨 · NCT07401381A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- City of Hope, Duarte
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- USC/Norris Comprehensive Cancer Center, Los Angeles
- 외 1개
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07287098A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Community Cancer Institute, Clovis
- City of Hope, Duarte
- Epic Care - Emeryville, Emeryville
- 외 19개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07114601Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- University of California Irvine, Irvine
- University of California Los Angeles, Los Angeles
- University of California Davis, Sacramento
- 외 2개
피험자 모집 중건강한 지원자 환영
30세 ~ 74세 · 여성 · 2026. 9. 21. 업데이트됨 · NCT02620852A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Disney Family Cancer Center, Burbank
- City of Hope, Corona
- City of Hope Comprehensive Cancer Center, Duarte
- 외 2개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 21. 업데이트됨 · NCT05894239Pulsed Electric Field Ablation for Metastatic Breast Cancer
- University of California San Francisco, San Francisco
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT07487844A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Duarte
- City of Hope, Irvine, Irvine
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07109726ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- University Of California - San Diego Moores Cancer Center, La Jolla
- Cancer and Blood Specialty Clinic (CBSC), Los Alamitos
- Cedar Sinai - Samuel Oschin Cancer Center, Los Angeles
- 외 4개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07173751ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health
- UC Davis, Sacramento
피험자 모집 중관찰 연구
18세 ~ 94세 · 여성 · 2026. 9. 17. 업데이트됨 · NCT07505797A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Beverly Hills Cancer Center, Beverly Hills
- Hoag Memorial Hospital Presbyterian, Newport Beach
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT06827236A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
- University of California, Los Angeles (Specimen Analysis only), Los Angeles
피험자 모집 중관찰 연구건강한 지원자 환영
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT06780176The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
피험자 모집 중1/2상
12세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT04585750A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
- UCSF Cancer Center Berkeley, Berkeley
- Cedars-Sinai Cancer Beverly Hills, Beverly Hills
- City of Hope National Medical Center, Duarte
- 외 19개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
- Orange Coast Medical Center, Fountain Valley
피험자 모집 중3상
18세 이상 · 여성 · 2026. 9. 14. 업데이트됨 · NCT07541079A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05123482Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- 외 1개
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06293898A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- City of Hope - Duarte, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center, Irvine
- University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla
- 외 1개
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT03424005Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
- UCLA Hematology/Oncology - Parkside ( Site 0021), Santa Monica
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 10. 업데이트됨 · NCT06797635Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
- Glendale Adventist Medical Center d/b/a Adventist Health Glendale, Glendale
피험자 모집 중
70세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07629206Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Providence Medical Foundation, Fullerton
- California Research Institute, Los Angeles
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT05386108A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- USC/Norris Comprehensive Cancer Center, Los Angeles
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06440005ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.